Latest news
AMPH: Revenue up 5% to $183.9M, margin expansion, and robust pipeline progress despite challenges - tradingview.comtradingview.com · Thu, 06 Aug 2026 23:20:02 GMTAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary - tradingview.comtradingview.com · Thu, 06 Aug 2026 21:40:31 GMTAMPH: Q2 2026 revenues grew 5% to $183.9M, with strong margins and a major BAQSIMI® milestone achieved - tradingview.comtradingview.com · Thu, 06 Aug 2026 20:54:48 GMTAMPH: Strong revenue growth and pipeline expansion driven by proprietary and biosimilar focus - tradingview.comtradingview.com · Thu, 06 Aug 2026 20:22:20 GMTAmphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026 - tradingview.comtradingview.com · Thu, 06 Aug 2026 20:05:00 GMTAmphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 - tradingview.comtradingview.com · Wed, 29 Jul 2026 07:00:00 GMTLive Nation to Post Q2 Earnings: What's in the Cards for the Stock? - tradingview.comtradingview.com · Tue, 28 Jul 2026 13:48:00 GMT